Yeah, I know: you’ve never heard of “C-reactive protein” (CRP) as an indicator of heart disease, just like you’d never heard of restless leg syndrome, irritable bowel syndrome or a host of other ailments before they were heralded in pharmaceutical company commercials 24-7. But soon, you’ll know all about C-reactive protein — and why if your CRP levels are high, you need to take Crestor.
Crestor is a statin prescribed to people with high cholesterol levels. But now a new study (funded by the maker of Crestor) says the drug is also therapeutic for patients whose cholesterol isn’t high, but who have high levels of C-reactive protein, which indicates inflammation in the body. The study says Crestor can reduce the risk of heart attack and stroke by half among individuals with this indicator.
Doctors and other experts have two concerns about the study: (1) it was funded by AstraZeneca, Crestor’s manufacturer, and (2) it could dramatically increase the number of patients who are prescribed Crestor, increasing U.S. healthcare costs by as much at $10 billion per year.
Here’s our advice: wait for more studies.
In the meantime, you should educate yourself about CRP with this information from the American Heart Association.